Patients taking doses. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms3

Sphingomonadaceae Helicobacter pylori Rats, Sprague-Dawley

Diseases43

Myiasis Nocturnal Enuresis Stomach Ulcer Peptic Ulcer Gastrointestinal Hemorrhage Hematemesis Peptic Ulcer Hemorrhage Gastrointestinal Diseases Epilepsy Duodenal Ulcer Hypertension Arthritis, Rheumatoid Hemorrhage Postoperative Hemorrhage Recurrence Asthma HIV Infections Diabetes Mellitus Neoplasms Chronic Disease Atrial Fibrillation Heart Failure Osteoarthritis Helicobacter Infections Gastritis Pain Osteoporosis Hypercholesterolemia Myocardial Infarction Diabetes Mellitus, Type 2 Thromboembolism Cardiovascular Diseases Parkinson Disease Stroke Colitis, Ulcerative Kidney Diseases Acute Disease Gastroesophageal Reflux Crohn Disease Breast Neoplasms Disease Progression Coronary Disease Postoperative Complications

Chemicals and Drugs95

Aspirin Warfarin Anticonvulsants Phenytoin Risperidone Antipsychotic Agents Anticoagulants Proton Pump Inhibitors Benzodiazepines Adrenergic beta-Antagonists Platelet Aggregation Inhibitors Sodium Chloride Symporter Inhibitors Placebos Carbamazepine Dibenzothiazepines Delayed-Action Preparations Naproxen Clozapine Hydroxymethylglutaryl-CoA Reductase Inhibitors Diuretics Triamterene Cyclooxygenase Inhibitors Amiodarone Mesalamine Ticlopidine Bendroflumethiazide Digoxin Atenolol Anti-Ulcer Agents Hydroxychloroquine Beclomethasone Immunosuppressive Agents Histamine H2 Antagonists Antihypertensive Agents Lithium Carbonate Ranitidine Methyldopa Hippurates Hypoglycemic Agents Valproic Acid Azathioprine Antirheumatic Agents Drug Combinations Monocrotophos Adrenal Cortex Hormones Angiotensin-Converting Enzyme Inhibitors Anti-Inflammatory Agents Pyridones Salicylates Sulfonylurea Compounds Serotonin Uptake Inhibitors Glucocorticoids Prednisolone Anticholesteremic Agents Contraceptives, Oral Sulfones Anti-HIV Agents HIV Protease Inhibitors Diclofenac Metoprolol Methotrexate Anti-Anxiety Agents Heptanoic Acids Hydrochlorothiazide Piperazines Anti-Arrhythmia Agents Pravastatin Cyclooxygenase 2 Inhibitors Thiophenes Bone Density Conservation Agents Dopamine Agonists Omeprazole Calcium Channel Blockers Simvastatin Sulfonamides Antineoplastic Agents Pyrazoles Bronchodilator Agents Triazoles Antidepressive Agents Thyroxine Anti-Asthmatic Agents Pyridines Pyrroles Prednisone Biological Markers Captopril Reverse Transcriptase Inhibitors Thyrotropin Pyrimidines Blood Glucose Antineoplastic Agents, Hormonal Insulin Hemoglobin A, Glycosylated Cyclooxygenase 2

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Double-Blind Method Drug Therapy, Combination Drug Administration Schedule Administration, Oral Treatment Outcome International Normalized Ratio Retrospective Studies Drug Monitoring Prospective Studies Product Surveillance, Postmarketing Placebos Risk Factors Delayed-Action Preparations Cohort Studies Follow-Up Studies Clinical Trials as Topic Radiation Dosage Lethal Dose 50 Administration, Inhalation Random Allocation Area Under Curve Drug Therapy Risk Assessment Drug Evaluation Analysis of Variance Radiometry Severity of Illness Index Cross-Sectional Studies Single-Blind Method Case-Control Studies Multivariate Analysis Diet, Vegetarian Questionnaires Incidence Randomized Controlled Trials as Topic Matched-Pair Analysis Logistic Models Cross-Over Studies Odds Ratio Heart Rate Drug Prescriptions Ambulatory Care Treatment Failure Statistics, Nonparametric Dose Fractionation Radiotherapy Dosage Predictive Value of Tests Long-Term Care Linear Models Chromatography, High Pressure Liquid Pain Measurement Injections, Intravenous Antiretroviral Therapy, Highly Active Risk Electrocardiography Prevalence Medical Records Combined Modality Therapy Pilot Projects Sensitivity and Specificity Infusions, Intravenous Radioimmunoassay Medical History Taking Radiotherapy Planning, Computer-Assisted Reproducibility of Results Reference Values Hospitalization Prognosis Confidence Intervals Chi-Square Distribution Exercise Test Survival Rate Proportional Hazards Models Body Burden Thermoluminescent Dosimetry Metabolic Clearance Rate Regression Analysis Injections, Subcutaneous

Psychiatry and Psychology6

Nocturnal Enuresis Patient Compliance Medication Adherence Schizophrenia Pain Smoking

Phenomena and Processes20

Drug Interactions Time Factors Dose-Response Relationship, Drug Radiation Dosage Lethal Dose 50 Area Under Curve Half-Life Diet, Vegetarian Odds Ratio Heart Rate Pain Platelet Aggregation Risk Sensitivity and Specificity Bone Density Genotype Chi-Square Distribution Biological Availability Metabolic Clearance Rate Polymorphism, Genetic

Disciplines and Occupations1

Family Practice

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Patient Education as Topic

Humanities1

Quality of Life

Information Science6

Questionnaires Incidence Prevalence Medical Records Radiotherapy Planning, Computer-Assisted Survival Rate

Named Groups1

Health Care59

Double-Blind Method Treatment Outcome Retrospective Studies Prospective Studies Patient Compliance Risk Factors Cohort Studies Follow-Up Studies Clinical Trials as Topic Radiation Dosage Random Allocation Area Under Curve Risk Assessment Medication Adherence Analysis of Variance Severity of Illness Index Cross-Sectional Studies Single-Blind Method Case-Control Studies Multivariate Analysis Questionnaires Incidence Randomized Controlled Trials as Topic Drug Utilization Review Matched-Pair Analysis Age Factors Logistic Models Cross-Over Studies Odds Ratio Drug Costs Drug Prescriptions Ambulatory Care Treatment Failure Statistics, Nonparametric Predictive Value of Tests Point-of-Care Systems Long-Term Care Linear Models Physician's Practice Patterns Managed Care Programs Risk Sex Factors Prevalence Comorbidity Medical Records Pilot Projects Sensitivity and Specificity Practice Guidelines as Topic Reproducibility of Results Hospitalization Confidence Intervals Patient Education as Topic Chi-Square Distribution Survival Rate Proportional Hazards Models Body Burden Thermoluminescent Dosimetry Relative Biological Effectiveness Regression Analysis

Geographicals3

United States Great Britain England

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Double-Blind Method Myiasis Aspirin Drug Therapy, Combination Drug Administration Schedule Administration, Oral Treatment Outcome Drug Interactions Warfarin International Normalized Ratio Anticonvulsants Phenytoin Time Factors Risperidone Antipsychotic Agents Retrospective Studies Nocturnal Enuresis Anticoagulants Proton Pump Inhibitors Benzodiazepines Drug Monitoring Adrenergic beta-Antagonists Platelet Aggregation Inhibitors Prospective Studies Product Surveillance, Postmarketing Sodium Chloride Symporter Inhibitors Patient Compliance Placebos Stomach Ulcer Carbamazepine Risk Factors Dibenzothiazepines Peptic Ulcer Delayed-Action Preparations Naproxen Clozapine Hydroxymethylglutaryl-CoA Reductase Inhibitors Diuretics Triamterene Cohort Studies Cyclooxygenase Inhibitors Follow-Up Studies Gastrointestinal Hemorrhage Hematemesis Clinical Trials as Topic Amiodarone Mesalamine Ticlopidine Peptic Ulcer Hemorrhage Gastrointestinal Diseases Dose-Response Relationship, Drug Bendroflumethiazide Digoxin Atenolol Anti-Ulcer Agents Hydroxychloroquine Beclomethasone Radiation Dosage Immunosuppressive Agents Epilepsy Lethal Dose 50 Histamine H2 Antagonists Antihypertensive Agents Lithium Carbonate Administration, Inhalation Ranitidine Methyldopa Hippurates Random Allocation Hypoglycemic Agents Valproic Acid Duodenal Ulcer Hypertension Area Under Curve Azathioprine Antirheumatic Agents Drug Combinations Monocrotophos Arthritis, Rheumatoid Adrenal Cortex Hormones Drug Therapy Angiotensin-Converting Enzyme Inhibitors Anti-Inflammatory Agents Pyridones Half-Life Hemorrhage Risk Assessment Postoperative Hemorrhage Drug Evaluation Salicylates Sulfonylurea Compounds Recurrence Serotonin Uptake Inhibitors Glucocorticoids Prednisolone Medication Adherence Analysis of Variance Asthma Radiometry Severity of Illness Index

No FAQ available that match "patients taking doses"